AR and neoplasm: Targeting of 6PGD was associated with two important tumour-suppressive mechanisms: firstly, it increased the activity of the AMP-activated protein kinase (AMPK); secondly, it enhanced AR ubiquitylation, leading to a reduction in AR protein levels and activity.